Search research articles
Contact Us
Filters
Showing results (141-150 of 186) with videos related to
Page
of 19
Sort By:
Arzneimittel-Forschung
|
April 1, 1988
Antihypertensive and angiotensin converting enzyme inhibitory activities of a novel dihydrobenzofuran analogue
T C Hamilton, D R Howlett, S D Longman, et al.
Cancer Research
|
October 15, 1995
Time-dependent pharmacodynamic models in cancer chemotherapy: population pharmacodynamic model for glutathione depletion following modulation by buthionine sulfoximine (BSO) in a Phase I trial of melphalan and BSO
J M Gallo, J Brennan, T C Hamilton, et al.
Arzneimittel-Forschung
|
April 1, 1991
Antihypertensive and haemodynamic properties of the potassium channel activating (-) enantiomer of cromakalim in animal models
J C Clapham, T C Hamilton, S D Longman, et al.
Journal of the National Cancer Institute
|
April 15, 1992
Spontaneous transformation of rat ovarian surface epithelial cells: association with cytogenetic changes and implications of repeated ovulation in the etiology of ovarian cancer
A K Godwin, J R Testa, L M Handel, et al.
Behavioural Brain Research
|
August 1, 1996
Motor dysfunction in a photothrombotic focal ischaemia model
N I Wood, B V Sopesen, J C Roberts, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 1987
Verapamil and adriamycin in the treatment of drug-resistant ovarian cancer patients
R F Ozols, R E Cunnion, R W Klecker, et al.
Experimental Neurology
|
December 17, 1997
Effects of isradipine, an L-type calcium channel blocker on permanent and transient focal cerebral ischemia in spontaneously hypertensive rats
C A Campbell, K B Mackay, S Patel, et al.
Cancer Research
|
May 15, 1995
Characterization of chromosome 9 in human ovarian neoplasia identifies frequent genetic imbalance on 9q and rare alterations involving 9p, including CDKN2
D C Schultz, L Vanderveer, K H Buetow, et al.
American Journal of Obstetrics and Gynecology
|
September 1, 1996
Development and characterization of a clinically useful animal model of epithelial ovarian cancer in the Fischer 344 rat
G S Rose, L M Tocco, G A Granger, et al.
Cancer Research
|
November 15, 1994
Relationship between platinum-DNA adduct formation and removal and cisplatin cytotoxicity in cisplatin-sensitive and -resistant human ovarian cancer cells
S W Johnson, P A Swiggard, L M Handel, et al.
Page
of 19
Search research articles
Search
Showing results (141-150 of 186) with videos related to
Sort By:
Page
of 19
Arzneimittel-Forschung
|
April 1, 1988
Antihypertensive and angiotensin converting enzyme inhibitory activities of a novel dihydrobenzofuran analogue
T C Hamilton, D R Howlett, S D Longman, et al.
Cancer Research
|
October 15, 1995
Time-dependent pharmacodynamic models in cancer chemotherapy: population pharmacodynamic model for glutathione depletion following modulation by buthionine sulfoximine (BSO) in a Phase I trial of melphalan and BSO
J M Gallo, J Brennan, T C Hamilton, et al.
Arzneimittel-Forschung
|
April 1, 1991
Antihypertensive and haemodynamic properties of the potassium channel activating (-) enantiomer of cromakalim in animal models
J C Clapham, T C Hamilton, S D Longman, et al.
Journal of the National Cancer Institute
|
April 15, 1992
Spontaneous transformation of rat ovarian surface epithelial cells: association with cytogenetic changes and implications of repeated ovulation in the etiology of ovarian cancer
A K Godwin, J R Testa, L M Handel, et al.
Behavioural Brain Research
|
August 1, 1996
Motor dysfunction in a photothrombotic focal ischaemia model
N I Wood, B V Sopesen, J C Roberts, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 1987
Verapamil and adriamycin in the treatment of drug-resistant ovarian cancer patients
R F Ozols, R E Cunnion, R W Klecker, et al.
Experimental Neurology
|
December 17, 1997
Effects of isradipine, an L-type calcium channel blocker on permanent and transient focal cerebral ischemia in spontaneously hypertensive rats
C A Campbell, K B Mackay, S Patel, et al.
Cancer Research
|
May 15, 1995
Characterization of chromosome 9 in human ovarian neoplasia identifies frequent genetic imbalance on 9q and rare alterations involving 9p, including CDKN2
D C Schultz, L Vanderveer, K H Buetow, et al.
American Journal of Obstetrics and Gynecology
|
September 1, 1996
Development and characterization of a clinically useful animal model of epithelial ovarian cancer in the Fischer 344 rat
G S Rose, L M Tocco, G A Granger, et al.
Cancer Research
|
November 15, 1994
Relationship between platinum-DNA adduct formation and removal and cisplatin cytotoxicity in cisplatin-sensitive and -resistant human ovarian cancer cells
S W Johnson, P A Swiggard, L M Handel, et al.
Page
of 19